Annual CFO:
-$414.19M+$60.62M(+12.77%)Summary
- As of today, RARE annual cash from operations is -$414.19 million, with the most recent change of +$60.62 million (+12.77%) on December 31, 2024.
- During the last 3 years, RARE annual cash from operations has fallen by -$75.49 million (-22.29%).
- RARE annual cash from operations is now -7010.52% below its all-time high of -$5.83 million, reached on December 31, 2011.
Performance
RARE Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
-$108.27M+$58.20M(+34.96%)Summary
- As of today, RARE quarterly cash from operations is -$108.27 million, with the most recent change of +$58.20 million (+34.96%) on June 30, 2025.
- Over the past year, RARE quarterly cash from operations has dropped by -$31.31 million (-40.68%).
- RARE quarterly cash from operations is now -223.95% below its all-time high of $87.35 million, reached on June 30, 2020.
Performance
RARE Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$421.25M-$31.31M(-8.03%)Summary
- As of today, RARE TTM cash from operations is -$421.25 million, with the most recent change of -$31.31 million (-8.03%) on June 30, 2025.
- Over the past year, RARE TTM cash from operations has increased by +$48.22 million (+10.27%).
- RARE TTM cash from operations is now -11942.48% below its all-time high of -$3.50 million, reached on September 1, 2012.
Performance
RARE TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
RARE Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +12.8% | -40.7% | +10.3% |
| 3Y3 Years | -22.3% | -40.1% | -36.4% |
| 5Y5 Years | -19.9% | -223.9% | -197.1% |
RARE Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -22.3% | +12.8% | -61.6% | +43.2% | -22.3% | +17.2% |
| 5Y | 5-Year | -213.3% | +12.8% | -99.2% | +43.2% | -218.6% | +17.2% |
| All-Time | All-Time | -7010.5% | +12.8% | -223.9% | +43.2% | >-9999.0% | +17.2% |
RARE Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$108.27M(+35.0%) | -$421.25M(-8.0%) |
| Mar 2025 | - | -$166.47M(-109.4%) | -$389.94M(+5.9%) |
| Dec 2024 | -$414.19M(+12.8%) | -$79.50M(-18.7%) | -$414.19M(+1.1%) |
| Sep 2024 | - | -$67.00M(+13.0%) | -$418.59M(+10.8%) |
| Jun 2024 | - | -$76.96M(+59.6%) | -$469.47M(+7.7%) |
| Mar 2024 | - | -$190.73M(-127.3%) | -$508.67M(-7.1%) |
| Dec 2023 | -$474.81M(-24.8%) | -$83.90M(+28.8%) | -$474.81M(+1.3%) |
| Sep 2023 | - | -$117.87M(-1.5%) | -$481.24M(-4.9%) |
| Jun 2023 | - | -$116.16M(+25.9%) | -$458.71M(-9.3%) |
| Mar 2023 | - | -$156.87M(-73.6%) | -$419.81M(-10.3%) |
| Dec 2022 | -$380.46M(-12.3%) | -$90.34M(+5.2%) | -$380.46M(-10.5%) |
| Sep 2022 | - | -$95.34M(-23.4%) | -$344.47M(-11.6%) |
| Jun 2022 | - | -$77.26M(+34.3%) | -$308.77M(-4.0%) |
| Mar 2022 | - | -$117.52M(-116.3%) | -$296.87M(+12.3%) |
| Dec 2021 | -$338.69M(-156.2%) | -$54.34M(+8.9%) | -$338.69M(+2.3%) |
| Sep 2021 | - | -$59.65M(+8.7%) | -$346.80M(+0.7%) |
| Jun 2021 | - | -$65.36M(+59.0%) | -$349.12M(-77.7%) |
| Mar 2021 | - | -$159.35M(-155.1%) | -$196.41M(-48.6%) |
| Dec 2020 | -$132.22M(+61.7%) | -$62.45M(-0.8%) | -$132.22M(+6.8%) |
| Sep 2020 | - | -$61.97M(-170.9%) | -$141.81M(+15.8%) |
| Jun 2020 | - | $87.35M(+191.8%) | -$168.35M(+51.2%) |
| Mar 2020 | - | -$95.15M(-32.1%) | -$344.76M(+0.2%) |
| Dec 2019 | -$345.38M(-18.9%) | -$72.04M(+18.6%) | -$345.38M(-4.9%) |
| Sep 2019 | - | -$88.51M(+0.6%) | -$329.20M(-6.2%) |
| Jun 2019 | - | -$89.06M(+7.0%) | -$309.85M(-4.4%) |
| Mar 2019 | - | -$95.78M(-71.5%) | -$296.86M(-2.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$290.57M(-14.5%) | -$55.85M(+19.2%) | -$290.57M(+8.2%) |
| Sep 2018 | - | -$69.16M(+9.1%) | -$316.54M(-2.3%) |
| Jun 2018 | - | -$76.08M(+15.0%) | -$309.37M(-9.7%) |
| Mar 2018 | - | -$89.48M(-9.4%) | -$282.12M(-11.1%) |
| Dec 2017 | -$253.84M(-57.7%) | -$81.82M(-32.0%) | -$253.84M(-15.5%) |
| Sep 2017 | - | -$61.99M(-27.0%) | -$219.70M(-17.8%) |
| Jun 2017 | - | -$48.82M(+20.2%) | -$186.45M(-5.2%) |
| Mar 2017 | - | -$61.20M(-28.4%) | -$177.28M(-10.1%) |
| Dec 2016 | -$160.97M(-51.9%) | -$47.68M(-65.9%) | -$160.97M(-4.7%) |
| Sep 2016 | - | -$28.75M(+27.5%) | -$153.74M(+1.2%) |
| Jun 2016 | - | -$39.66M(+11.7%) | -$155.59M(-16.8%) |
| Mar 2016 | - | -$44.90M(-11.0%) | -$133.21M(-25.7%) |
| Dec 2015 | -$105.98M(-137.4%) | -$40.44M(-32.2%) | -$105.98M(-32.0%) |
| Sep 2015 | - | -$30.60M(-77.2%) | -$80.27M(-32.2%) |
| Jun 2015 | - | -$17.27M(+2.2%) | -$60.70M(-12.5%) |
| Mar 2015 | - | -$17.66M(-19.8%) | -$53.96M(-20.9%) |
| Dec 2014 | -$44.63M(-43.1%) | -$14.74M(-33.6%) | -$44.63M(-12.5%) |
| Sep 2014 | - | -$11.03M(-4.8%) | -$39.67M(-12.1%) |
| Jun 2014 | - | -$10.53M(-26.3%) | -$35.38M(-6.4%) |
| Mar 2014 | - | -$8.34M(+14.7%) | -$33.24M(-6.5%) |
| Dec 2013 | -$31.20M(-149.5%) | -$9.77M(-44.8%) | -$31.20M(-24.1%) |
| Sep 2013 | - | -$6.75M(+19.6%) | -$25.14M(-14.8%) |
| Jun 2013 | - | -$8.39M(-33.3%) | -$21.89M(-62.1%) |
| Mar 2013 | - | -$6.29M(-69.4%) | -$13.51M(-87.3%) |
| Dec 2012 | -$12.50M(-114.7%) | -$3.71M(-6.2%) | -$7.21M(-106.2%) |
| Sep 2012 | - | -$3.50M | -$3.50M |
| Dec 2011 | -$5.83M | - | - |
FAQ
- What is Ultragenyx Pharmaceutical Inc. annual cash from operations?
- What is the all-time high annual cash from operations for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. annual cash from operations year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. quarterly cash from operations year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. TTM cash from operations year-on-year change?
What is Ultragenyx Pharmaceutical Inc. annual cash from operations?
The current annual cash from operations of RARE is -$414.19M
What is the all-time high annual cash from operations for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high annual cash from operations is -$5.83M
What is Ultragenyx Pharmaceutical Inc. annual cash from operations year-on-year change?
Over the past year, RARE annual cash from operations has changed by +$60.62M (+12.77%)
What is Ultragenyx Pharmaceutical Inc. quarterly cash from operations?
The current quarterly cash from operations of RARE is -$108.27M
What is the all-time high quarterly cash from operations for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high quarterly cash from operations is $87.35M
What is Ultragenyx Pharmaceutical Inc. quarterly cash from operations year-on-year change?
Over the past year, RARE quarterly cash from operations has changed by -$31.31M (-40.68%)
What is Ultragenyx Pharmaceutical Inc. TTM cash from operations?
The current TTM cash from operations of RARE is -$421.25M
What is the all-time high TTM cash from operations for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high TTM cash from operations is -$3.50M
What is Ultragenyx Pharmaceutical Inc. TTM cash from operations year-on-year change?
Over the past year, RARE TTM cash from operations has changed by +$48.22M (+10.27%)